Medical treatments for incomplete miscarriage

Area of Science:

• Obstetrics and Gynecology
• Reproductive Medicine
• Clinical Trials Research

Background:

• Miscarriage affects 10-15% of pregnancies.
• Surgical evacuation of the uterus is a traditional treatment for retained placental tissue.
• Medical management and expectant care are emerging alternatives.

Purpose of the Study:

• To evaluate the effectiveness, safety, and acceptability of medical treatments for incomplete miscarriage (before 24 weeks).
• To compare medical treatments against expectant care and surgical evacuation.

Main Methods:

• Systematic review of randomized controlled trials (RCTs).
• Searched Cochrane Pregnancy and Childbirth's Trials Register and reference lists.
• Included 24 RCTs involving 5577 women; assessed risk of bias and evidence quality (GRADE).

Main Results:

• Misoprostol vs. expectant care showed no significant difference in complete miscarriage or need for surgery.
• Misoprostol vs. surgery resulted in slightly lower complete miscarriage rates but significantly fewer surgical evacuations.
• Medical management led to more unplanned procedures and gastrointestinal side effects (nausea, vomiting, diarrhea) but comparable patient satisfaction.

Conclusions:

• Medical treatment (misoprostol) and expectant care are acceptable alternatives to surgical evacuation for miscarriage.
• Availability of health service resources is crucial for supporting all management approaches.
• Further research, especially for later gestations (>13 weeks), is needed to confirm findings and long-term outcomes.